KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
